For citations:
FDA Has Approved First Drug for Treatment of Congenital Athymia. Pediatric pharmacology. 2021;18(5):436. (In Russ.) https://doi.org/10.15690/pf.v18i5.2336
FDA Has Approved First Drug for Treatment of Congenital Athymia. Pediatric pharmacology. 2021;18(5):436. (In Russ.) https://doi.org/10.15690/pf.v18i5.2336